Ticker >

Kobo Biotech share price

Kobo Biotech Ltd.

BSE: 531541 SECTOR: Pharmaceuticals & Drugs  6046   11   0

3.80
-0.20 (-5.00%)
BSE: 28 Mar 4:00 PM

Price Summary

Today's High

₹ 4

Today's Low

₹ 3.8

52 Week High

₹ 6.01

52 Week Low

₹ 1.86

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

9.05 Cr.

Enterprise Value

148.77 Cr.

No. of Shares

2.38 Cr.

P/E

0

P/B

0

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  -55.26

CASH

0.13 Cr.

DEBT

139.84 Cr.

Promoter Holding

44.95 %

EPS (TTM)

₹  -2.29

Sales Growth

0%

ROE

0 %

ROCE

-36.84%

Profit Growth

63.53 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 YearNA
3 YearNA
5 YearNA

Profit Growth

1 Year63.53%
3 Year20.18%
5 Year12.07%

ROE%

1 Year0%
3 Year0%
5 Year0%

ROCE %

1 Year-36.84%
3 Year-19.91%
5 Year-13.88%

Debt/Equity

-1.0927

Price to Cash Flow

10.35

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 44.95 0
Sep 2023 44.95 0
Jun 2023 44.95 0
Mar 2023 44.95 0
Dec 2022 44.95 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of 0 days.

 Limitations

  • Company has a poor ROE of 0% over the past 3 years.
  • Company has a poor ROCE of -19.912277275176% over the past 3 years
  • The company has a low EBITDA margin of 0% over the past 5 years.
  • The company has negative book value.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 0 0 0 0 0
Total Expenditure 0.17 0.79 0.23 0.2 0.2
Operating Profit -0.17 -0.79 -0.23 -0.2 -0.2
Other Income 0 0 0.02 0 0
Interest 0 0 0 0 0
Depreciation 1.03 1 1.01 1.02 1.03
Exceptional Items 0 0 0 0 0
Profit Before Tax -1.19 -1.79 -1.23 -1.22 -1.23
Tax 0 0 0 0 0
Profit After Tax -1.19 -1.79 -1.23 -1.22 -1.23
Adjusted EPS (Rs) -0.5 -0.75 -0.51 -0.51 -0.52

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 0 0 0 0 0
Total Expenditure 2.99 2.61 2.79 143.87 1.5
Operating Profit -2.99 -2.61 -2.79 -143.87 -1.5
Other Income 1.31 1.95 0.04 133.38 0.02
Interest 14.44 14.47 10.84 0.13 0
Depreciation 6.15 5.88 5.64 4.61 4.07
Exceptional Items -2.18 0 0 0 0
Profit Before Tax -24.46 -21.01 -19.23 -15.23 -5.55
Tax 0 0 0 0 0
Net Profit -24.46 -21.01 -19.23 -15.23 -5.55
Adjusted EPS (Rs.) -10.27 -8.82 -8.07 -6.39 -2.33

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 23.83 23.83 23.83 23.83 23.83
Total Reserves -90.79 -111.8 -131.03 -146.25 -151.81
Borrowings 34.93 34.93 33.53 33.53 32.66
Other N/C liabilities 5.1 5.1 5.1 4.77 4.77
Current liabilities 266.38 284.27 299.16 163.31 165.88
Total Liabilities 239.45 236.33 230.59 79.19 75.33
Assets
Net Block 68.42 62.54 56.91 41.66 37.59
Capital WIP 2.25 2.25 2.25 0 0
Intangible WIP 0 0 0 0 0
Investments 12.19 12.19 12.19 0 0
Loans & Advances 0.01 0.01 0.01 0 0
Other N/C Assets 0 0 0 0 0
Current Assets 156.58 159.34 159.23 37.53 37.74
Total Assets 239.45 236.33 230.59 79.19 75.33
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations -24.46 -21.01 -19.23 -15.23 -5.55
Adjustment 20.59 20.35 16.48 4.74 4.07
Changes in Assets & Liabilities 24.82 15.13 5.26 104.24 2.36
Tax Paid 0 0 0 0 0
Operating Cash Flow 20.95 14.48 2.51 93.76 0.87
Investing Cash Flow 0 0 0 25.09 0
Financing Cash Flow -20.95 -14.47 -1.08 -120.28 -0.87
Net Cash Flow 0 0 1.43 -1.43 0

Corporate Actions

Investors Details

PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
promoters 44.95 44.95 44.95 44.95 44.95
arch pharmalabs ltd 44.95 44.95 44.95 44.95 44.95
PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
investors 55.05 55.05 55.05 55.05 55.05
mehul pravin chandra shah... 1.10 1.10 1.10 1.10 1.10
sanjay luthra 1.06 1.06 1.06 1.06 1.06

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Kobo Biotech Stock Price Analysis and Quick Research Report. Is Kobo Biotech an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Kobo Biotech and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Kobo Biotech cash from the operating activity was Rs 0.8746 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Kobo Biotech has a Debt to Equity ratio of -1.0927 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Kobo Biotech , the EPS growth was 63.5266872173627 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Kobo Biotech has OPM of 0 % which is a bad sign for profitability.
     
  • ROE: Kobo Biotech have a poor ROE of 0 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Kobo Biotech is Rs 3.8. One can use valuation calculators of ticker to know if Kobo Biotech share price is undervalued or overvalued.
Last Updated on:
Brief about Kobo Biotech
X